ENTA Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

KUPNO 112029 min ago

@ $13.07

Wydano: 14 vas. 2024 @ 22:52

Zwrot: 3.71%

Poprzedni sygnał: vas. 14 - 16:30

Poprzedni sygnał: Sprzedaż

Zwrot: 4.73 %

Live Chart Being Loaded With Signals

Commentary (2 geg. 2024 @ 18:58):

Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases...

Stats
Dzisiejszy wolumen	18 254.00
Średni wolumen	228 881
Kapitalizacja rynkowa	286.66M
EPS	$0 ( 2024-02-07 )
Następna data zysków	( $-1.260 ) 2024-05-06
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-2.06
ATR14	$0.0350 (0.26%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-29	Kowalsky Matthew Paul	Buy	150 000	Stock Option (right to buy)
2024-04-29	Kowalsky Matthew Paul	Buy	0
2024-03-06	Vance Terry	Buy	15 700	Stock Option (right to buy)
2024-03-06	Russell Lesley	Buy	15 700	Stock Option (right to buy)
2024-03-06	Peterson Kristine	Buy	15 700	Stock Option (right to buy)

INSIDER POWER
75.20
Last 99 transactions
Buy: 1 413 491 \| Sell: 286 116

Wolumen Korelacja

Długi: -0.06 (neutral)

Krótki: -0.06 (neutral)

Signal:(46.938) Neutral

Enanta Pharmaceuticals Korelacja

10 Najbardziej pozytywne korelacje
MODV	0.977
CNXC	0.977
SBSI	0.975
NURO	0.975
HMST	0.974
TRVG	0.971
NWL	0.97
INDB	0.97
FSFG	0.97
TBNK	0.97

10 Najbardziej negatywne korelacje
AGGR	-0.983
TBSA	-0.983
LEGA	-0.982
ACQR	-0.981
AHRN	-0.977
FRON	-0.976
LGAC	-0.976
FRSG	-0.975
HERA	-0.975
CFIV	-0.975

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Enanta Pharmaceuticals Korelacja - Waluta/Towar

-0.45
( neutral )

-0.21
( neutral )

0.00
( neutral )

0.34
( neutral )

0.61
( weak )

0.38
( neutral )

Enanta Pharmaceuticals Finanse

Annual	2023
Przychody:	$79.20M
Zysk brutto:	$76.83M (97.01 %)
EPS:	$-6.38

FY	2023
Przychody:	$79.20M
Zysk brutto:	$76.83M (97.01 %)
EPS:	$-6.38

FY	2022
Przychody:	$86.16M
Zysk brutto:	$83.19M (96.55 %)
EPS:	$-5.91

FY	2021
Przychody:	$97.07M
Zysk brutto:	$0.00 (0.00 %)
EPS:	$-3.92

Financial Reports:

No articles found.

Enanta Pharmaceuticals

Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and license agreement with Abbott Laboratories to identify, develop, and commercialize HCV NS3 and NS3/4A protease inhibitor compounds, including paritaprevir and glecaprevir for the treatment of chronic hepatitis C virus. Enanta Pharmaceuticals, Inc. was founded in 1995 and is headquartered in Watertown, Massachusetts.

Aktualne aktualizacje dla Enanta Pharmaceuticals [ENTA]

Upcoming Earnings Alert